Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast activation and proliferation are key processes in tissue repair, fibrosis, and pathological remodeling. Quiescent fibroblasts become activated in response to injury or inflammation, transitioning into myofibroblasts characterized by increased proliferation, migration, ECM production, and expression of markers like αSMA and FAP. These processes are regulated by growth factors (e.g., TGFβ, PDGF), signaling cascades (e.g., mTOR, TRP channels), and mechanical stress. Dysregulation of fibroblast activation/proliferation contributes to diseases such as fibrosis, cancer, and chronic inflammation.
Varies depending on the specific target (e.g., inhibition of TGFβ signaling, blockade of PDGFR activation, etc.)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast Activation and Proliferation (N/A).